PH9976A - Process for the manufacture of quininone,quindinone and analogs thereof - Google Patents

Process for the manufacture of quininone,quindinone and analogs thereof

Info

Publication number
PH9976A
PH9976A PH12277A PH12277A PH9976A PH 9976 A PH9976 A PH 9976A PH 12277 A PH12277 A PH 12277A PH 12277 A PH12277 A PH 12277A PH 9976 A PH9976 A PH 9976A
Authority
PH
Philippines
Prior art keywords
quindinone
quininone
analogs
manufacture
Prior art date
Application number
PH12277A
Inventor
G Grentre
M Uskokovic
Original Assignee
G Grentre
M Uskokovic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by G Grentre, M Uskokovic filed Critical G Grentre
Priority to PH15319A priority Critical patent/PH9794A/en
Publication of PH9976A publication Critical patent/PH9976A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH12277A 1970-03-16 1971-03-09 Process for the manufacture of quininone,quindinone and analogs thereof PH9976A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PH15319A PH9794A (en) 1970-03-16 1973-12-13 Process for the manufacture of quinine,quinidine and analogs thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2003470A 1970-03-16 1970-03-16

Publications (1)

Publication Number Publication Date
PH9976A true PH9976A (en) 1976-06-16

Family

ID=21796376

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12277A PH9976A (en) 1970-03-16 1971-03-09 Process for the manufacture of quininone,quindinone and analogs thereof

Country Status (14)

Country Link
AT (1) AT341116B (en)
BE (1) BE764252A (en)
CA (1) CA940530A (en)
CH (2) CH590274A5 (en)
DE (1) DE2111938A1 (en)
DK (1) DK137189B (en)
FR (1) FR2100618B1 (en)
GB (1) GB1313963A (en)
IE (1) IE35284B1 (en)
IL (1) IL36400A (en)
NL (1) NL7103506A (en)
PH (1) PH9976A (en)
SE (1) SE395699B (en)
ZA (1) ZA711588B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH605916A5 (en) * 1973-12-07 1978-10-13 Hoffmann La Roche
FR2381044A1 (en) * 1977-02-17 1978-09-15 Hoffmann La Roche PROCESS FOR THE PREPARATION OF MEFLOQUINE
DE2860188D1 (en) * 1977-06-15 1981-01-08 Devinter Sa Novel method for the preparation of quinidine.
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
AU6941200A (en) 1999-08-27 2001-03-26 Ligand Pharmaceuticals Incorporated 8-substituted-6-trifluoromethyl-9-pyrido(3,2-g)quinoline compounds as androgen receptor modulators
BR0013597A (en) 1999-08-27 2002-07-16 Ligand Pharm Inc Androgen receptor modulating compounds and methods
PE20010647A1 (en) 1999-09-14 2001-06-23 Lilly Co Eli RETINOID X RECEPTOR MODULATORS (RXR) WITH IMPROVED PHARMACOLOGICAL PROFILE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH533123A (en) * 1968-07-02 1973-01-31 Hoffmann La Roche Quinine quininoine and analogues thereof useful as antimal

Also Published As

Publication number Publication date
SE395699B (en) 1977-08-22
CA940530A (en) 1974-01-22
IE35284L (en) 1971-09-16
DK137189C (en) 1978-07-03
FR2100618A1 (en) 1972-03-24
FR2100618B1 (en) 1974-08-23
IE35284B1 (en) 1976-01-07
GB1313963A (en) 1973-04-18
CH590274A5 (en) 1977-07-29
CH590275A5 (en) 1977-07-29
DK137189B (en) 1978-01-30
IL36400A (en) 1973-07-30
IL36400A0 (en) 1971-05-26
ATA220971A (en) 1977-05-15
AT341116B (en) 1978-01-25
ZA711588B (en) 1971-12-29
DE2111938A1 (en) 1971-10-07
BE764252A (en) 1971-09-15
NL7103506A (en) 1971-09-20

Similar Documents

Publication Publication Date Title
JPS5217449A (en) Process for manufacture of 155alkylprostaglandin
ZA715434B (en) Process for the manufacture of perfluoroalkyl iodide-olefine
YU40057B (en) Process for the polymerization of 1-olefines
ZA712326B (en) Process for the manufacture of amines
PH9976A (en) Process for the manufacture of quininone,quindinone and analogs thereof
IL37698A0 (en) Process for the manufacture of peptides
ZA715124B (en) Process for the preparation of 4-oxocapronitrile
ZA716693B (en) Process for the manufacture of phosgene
ZA711002B (en) Process for the continuous preparation of dichloropropanols
ZA713768B (en) Process for the manufacture of 1,1,2,2-tetrahydroperfluoro-alkanols
PH9228A (en) Process for the preparation of 3-phenyl-5-t-butyl-2-oxadiazolones
ZA711739B (en) Fluoralkyl-sulfur compounds and process for their manufacture
ZA718575B (en) Substituted dioxypiperidines and process for the preparation thereof
AU3246871A (en) Process for the preparation of isoprene
GB1364913A (en) Process for the preparation of isoprene
ZA714028B (en) Process for the manufacture of zeaxanthin
GB1323028A (en) Process for the manufacture of homogeneous copolymers
IL37238A (en) Process for the manufacture of a pyroglutamylpeptide
EG10440A (en) Process for the preparation of des-phenylalamin b1-insuli
ZA708690B (en) Process for the manufacture of 21-fluorosteroids
ZA708476B (en) Process for the preparation of isoxazolylethyl substituted tetrahydropyranols
ZA712516B (en) Process for the preparation of propionaldehyde
ZA712352B (en) Process for the manufacture of new halogenosteroids
ZA713078B (en) 4,5-oxido-bufa-dienolido-3-(rhamnosido-2',3'-dialkylorthocarbonates)and process for their manufacture
IL38029A (en) Process for the preparation of 14-anhydrobufaline